115 related articles for article (PubMed ID: 2867951)
1. Intrinsic activity and effects of guanyl-5'-yl imidodiphosphate, Gpp(NH)p and sodium ion on the affinity of dynorphin 1-13, nalorphine and nalorphine-7,8-oxide to kappa-opioid receptor.
Takayanagi I; Okumura K; Konno F; Koike K; Cho N; Hirobe M
Gen Pharmacol; 1985; 16(6):617-9. PubMed ID: 2867951
[TBL] [Abstract][Full Text] [Related]
2. Evidence that dynorphin-(1-13) acts as an agonist on opioid kappa-receptors.
Oka T; Negishi K; Suda M; Sawa A; Fujino M; Wakimasu M
Eur J Pharmacol; 1982 Jan; 77(2-3):137-41. PubMed ID: 6277659
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological effects of nalorphine and nalorphine-7,8-oxide (nalorphine-epoxide): interaction of the intrinsic activity, affinity and pharmacological responses.
Konno F; Kobayashi C; Morimoto R; Takayanagi I; Cho N; Hirobe M
Arch Int Pharmacodyn Ther; 1986 Aug; 282(2):219-32. PubMed ID: 2876689
[TBL] [Abstract][Full Text] [Related]
4. Kappa-receptor mechanisms in synaptosomal Ca uptake.
Toru T; Konno F; Takayanagi I; Hirobe M
Gen Pharmacol; 1989; 20(2):249-52. PubMed ID: 2565850
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of the mu-, delta-, and kappa-opiate receptor subtypes by guanyl nucleotides and metal ions.
Pfeiffer A; Sadée W; Herz A
J Neurosci; 1982 Jul; 2(7):912-7. PubMed ID: 6284888
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of opioid receptors in guinea-pig cerebellum and human placenta.
Ishizuka Y; Oka T; Kenjo T; Fujii A
Tokai J Exp Clin Med; 1986 Aug; 11(3):179-84. PubMed ID: 3039693
[TBL] [Abstract][Full Text] [Related]
7. Profile of activity of kappa receptor agonists in the rabbit vas deferens.
Hayes A; Kelly A
Eur J Pharmacol; 1985 Apr; 110(3):317-22. PubMed ID: 2988982
[TBL] [Abstract][Full Text] [Related]
8. Na+ ions and Gpp(NH)p selectively inhibit agonist interactions at mu- and kappa-opioid receptor sites in rabbit and guinea-pig cerebellum membranes.
Frances B; Moisand C; Meunier JC
Eur J Pharmacol; 1985 Nov; 117(2):223-32. PubMed ID: 2866971
[TBL] [Abstract][Full Text] [Related]
9. Irreversible blockade of the kappa-receptor by a newly synthesized dynorphin derivative containing a 3-nitro-2-pyridinesulfenyl group.
Koike K; Takayanagi I; Hirakura Y; Matsueda R
Arch Int Pharmacodyn Ther; 1991; 313():33-46. PubMed ID: 1687773
[TBL] [Abstract][Full Text] [Related]
10. Effects of guanyl nucleotides and ions on kappa opioid binding.
Mack KJ; Lee MF; Weyhenmeyer JA
Brain Res Bull; 1985 Apr; 14(4):301-6. PubMed ID: 2988712
[TBL] [Abstract][Full Text] [Related]
11. N,N-diallyl-tyrosyl substitution confers antagonist properties on the kappa-selective opioid peptide [D-Pro10]dynorphin A(1-11).
Gairin JE; Mazarguil H; Alvinerie P; Botanch C; Cros J; Meunier JC
Br J Pharmacol; 1988 Dec; 95(4):1023-30. PubMed ID: 2905908
[TBL] [Abstract][Full Text] [Related]
12. Binding of dynorphin A and related peptides to kappa- and mu-opioid receptors: sensitivity to Na+ ions and Gpp(NH)p.
Gairin JE; Botanch C; Cros J; Meunier JC
Eur J Pharmacol; 1989 Oct; 172(4-5):381-4. PubMed ID: 2573538
[TBL] [Abstract][Full Text] [Related]
13. Possible role of distinct morphine and enkephalin receptors in mediating actins of benzomorphan drugs (putative kappa and sigma agonists).
Chang KJ; Hazum E; Cuatrecasas P
Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4469-73. PubMed ID: 6254028
[TBL] [Abstract][Full Text] [Related]
14. Dynorphin is a specific endogenous ligand of the kappa opioid receptor.
Chavkin C; James IF; Goldstein A
Science; 1982 Jan; 215(4531):413-5. PubMed ID: 6120570
[TBL] [Abstract][Full Text] [Related]
15. Interaction of newly synthesized N-cyclopropylmethyl derivatives of (-)-6 beta-acetylthionormorphine with opioid receptors.
Takayanagi I; Goromaru N; Koike K; Konno F; Mori T; Yoshida M; Kanematsu K
Gen Pharmacol; 1990; 21(4):541-6. PubMed ID: 2165960
[TBL] [Abstract][Full Text] [Related]
16. Kappa opioid properties of dynorphin and its peptide fragments on the guinea-pig Ileum.
Yoshimura K; Huidobro-Toro JP; Lee NM; Löh HH; Way EL
J Pharmacol Exp Ther; 1982 Jul; 222(1):71-9. PubMed ID: 6123594
[No Abstract] [Full Text] [Related]
17. Regulation of opioid antagonist and mu, kappa or delta agonist binding by guanine nucleotide and sodium.
Ishizuka Y; Oka T
Jpn J Pharmacol; 1984 Nov; 36(3):397-405. PubMed ID: 6097726
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic activity and effects of guanyl-5'-yl imidodiphosphate, Gpp(NH)p on the affinity of partial agonists to the muscarinic receptor.
Takayanagi I; Koike K; Okumura K
Eur J Pharmacol; 1984 Mar; 99(1):107-10. PubMed ID: 6723787
[TBL] [Abstract][Full Text] [Related]
19. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
Su TP
J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939
[TBL] [Abstract][Full Text] [Related]
20. The choice of opioid receptor subtype in isolated preparations by dynorphins.
Oka T; Aoki K; Kajiwara M
Life Sci; 1983; 33 Suppl 1():311-4. PubMed ID: 6141492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
